Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P53 mutations in human cancer

C Miller1, H P Koeffler

  • 1Cedars-Sinai Medical Center, UCLA School of Medicine 90048.

Leukemia
|August 1, 1993
PubMed
Summary

The p53 tumor suppressor gene is frequently altered in human cancers. Its inactivation is a late event in cancer development, suggesting a critical role in preventing tumor progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sensory gating in a computer model of the CA3 neural network of the hippocampus.

Biological psychiatry·1996
Same author

Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model.

Archives of general psychiatry·1996
Same author

Iatrogenic scald burn: a consequence of institutional infection control measures.

Pediatrics·1996
Same author

Social skills training for drug prevention in high-risk female adolescents.

Preventive medicine·1996
Same author

A chloride channel model?

Science (New York, N.Y.)·1996
Same author

Reconstitution of mammalian pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes: analysis of protein X involvement and interaction of homologous and heterologous dihydrolipoamide dehydrogenases.

The Biochemical journal·1996

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The p53 protein, a 53,000-dalton molecule, was identified as mutated in human cancer in 1987.
  • p53 is a tumor suppressor gene frequently altered across various cancer types.
  • Alterations include interactions with viral antigens, mutations, and rearrangements.

Purpose of the Study:

  • To investigate the role of the p53 tumor suppressor gene in cancer development.
  • To understand the mechanisms by which p53 functions to prevent tumor formation.

Main Methods:

  • Analysis of p53 alterations in human cancers.
  • Transfection studies to examine p53 expression and its effects on cellular proliferation and apoptosis.
  • Irradiation studies in normal cells to induce p53 expression.
  • Studies of p53-deficient mice.

Main Results:

  • p53 acts by binding DNA and activating transcription.
  • p53 expression blocks cellular proliferation and induces apoptotic cell death.
  • p53 expression is induced by irradiation in normal cells, potentially inhibiting replication during genetic repair.
  • p53-deficient cells show increased susceptibility to gene amplification.
  • p53-deficient mice develop cancer later in life, indicating p53 is a late-acting factor.

Conclusions:

  • p53 is a critical tumor suppressor involved in preventing cancer progression.
  • Inactivation of p53 appears to be a late event in tumorigenesis.
  • Understanding p53's function is crucial for cancer therapy development.

Related Experiment Videos